Oscar Health price target raised to $25 from $22 at BofA

BofA analyst Adam Ron raised the firm’s price target on Oscar Health to $25 from $22 and keeps a Buy rating on the shares after having met with Oscar CFO Scott Blackley at the firm’s Healthcare Conference. Following the meet-up, the firm is raising its price target on higher confidence based on increased confidence in utilization trends, the analyst tells investors.